Filing Details
- Accession Number:
- 0001110803-14-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-14 19:28:37
- Reporting Period:
- 2014-05-14
- Filing Date:
- 2014-05-14
- Accepted Time:
- 2014-05-14 19:28:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1539796 | Marc Stapley | 5200 Illumina Way San Diego CA 92122 | Sr Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-14 | 1,422 | $36.30 | 23,418 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-14 | 622 | $145.93 | 22,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-14 | 400 | $146.80 | 22,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-14 | 400 | $148.66 | 21,996 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-05-14 | 1,422 | $0.00 | 1,422 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,673 | 2013-01-20 | 2022-01-20 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 622 shares sold ranging from $145.48 to $146.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 400 shares sold ranging from $146.49 to $147.34 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 400 shares sold ranging from $148.36 to $149.03 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
